UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 298

Sortiert nach

Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders

Chemical reviews, 2007-01, Vol.107 (1), p.274-302

2007

Link zum Volltext

Verfügbarkeit prüfen

Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders

Chemical reviews, 2013-05, Vol.113 (5), p.PR123-PR178

2013

Link zum Volltext

Verfügbarkeit prüfen

The Non-Anhydrous, Minimally Basic Synthesis of the Dopamine D2 Agonist [18F]MCL-524

Chemistry an international journal, 2021-09, Vol.3 (3), p.1047-1056

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of fluorinated (R)-(-)-aporphine derivatives as potent and selective ligands at serotonin 5-HT 2C receptor

Bioorganic & medicinal chemistry letters, 2019-01, Vol.29 (2), p.230

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification of fluorinated (R)-(−)-aporphine derivatives as potent and selective ligands at serotonin 5-HT2C receptor

Bioorganic & medicinal chemistry letters, 2019-01, Vol.29 (2), p.230-233

2019

Link zum Volltext

Verfügbarkeit prüfen

The High Affinity Dopamine D 2 Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological Disorders

ACS chemical neuroscience, 2021-04, Vol.12 (8), p.1428-1437

2021

Link zum Volltext

Verfügbarkeit prüfen

The High Affinity Dopamine D2 Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological Disorders

ACS chemical neuroscience, 2021-04, Vol.12 (8), p.1428-1437

2021

Link zum Volltext

Verfügbarkeit prüfen

Arylbenzazepines are potent modulators for the delayed rectifier K+ channel: a potential mechanism for their neuroprotective effects

PloS one, 2009-06, Vol.4 (6), p.e5811

2009

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of 2-Fluoro-11-hydroxy-N-propylnoraporphine: A Potential Dopamine D2 Agonist

Organic letters, 2005-07, Vol.7 (15), p.3239-3242

2005

Link zum Volltext

Verfügbarkeit prüfen

A Tribute to Joseph G. Cannon, 1926–2011

Journal of medicinal chemistry, 2012-02, Vol.55 (4), p.1423-1423

Neumeyer, John L

2012

Link zum Volltext

Verfügbarkeit prüfen

A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey

Nuclear medicine and biology, 2005-05, Vol.32 (4), p.353-360

2005

Link zum Volltext

Verfügbarkeit prüfen

Advances in Development of Dopaminergic Aporphinoids

Journal of medicinal chemistry, 2007-01, Vol.50 (2), p.171-181

2007

Link zum Volltext

Verfügbarkeit prüfen

The Non-Anhydrous, Minimally Basic Synthesis of the Dopamine D 2 Agonist [18F]MCL-524

Chemistry an international journal, 2021-09, Vol.3 (3), p.1047

2021

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Pharmacological Evaluation of Aminothiazolomorphinans at the Mu and Kappa Opioid Receptors

Journal of medicinal chemistry, 2013-11, Vol.56 (21), p.8872-8878

2013

Link zum Volltext

Verfügbarkeit prüfen

Microwave-Promoted Pd-Catalyzed Cyanation of Aryl Triflates: A Fast and Versatile Access to 3-Cyano-3-desoxy-10-ketomorphinans

Organic letters, 2003-01, Vol.5 (2), p.201-203

2003

Link zum Volltext

Verfügbarkeit prüfen

Rapid access to morphinones: removal of 4,5-ether bridge with Pd-catalyzed triflate reduction

Tetrahedron letters, 2010-04, Vol.51 (17), p.2359-2361

2010

Link zum Volltext

Verfügbarkeit prüfen

Kappa receptor bivalent ligands

Current topics in medicinal chemistry, 2007-02, Vol.7 (4), p.363

2007

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors

Bioorganic & medicinal chemistry, 2011-05, Vol.19 (9), p.2808-2816

2011

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Opioid Receptor Binding Affinities of 2-Substituted and 3-Aminomorphinans: Ligands for μ, κ, and δ Opioid Receptors

Journal of medicinal chemistry, 2010-01, Vol.53 (1), p.402-418

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors

Journal of medicinal chemistry, 2007-05, Vol.50 (9), p.2254-2258

2007

Link zum Volltext

Verfügbarkeit prüfen

Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines

European journal of pharmacology, 2003-08, Vol.474 (2), p.137-140

2003

Link zum Volltext

Verfügbarkeit prüfen

Aminothiazolomorphinans with Mixed κ and μ Opioid Activity

Journal of medicinal chemistry, 2011-03, Vol.54 (6), p.1903-1913

2011

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, Binding Affinity, and Functional in Vitro Activity of 3-Benzylaminomorphinan and 3-Benzylaminomorphine Ligands at Opioid Receptors

Journal of medicinal chemistry, 2012-04, Vol.55 (8), p.3878-3890

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with κ agonist and μ agonist/antagonist activity

European journal of pharmacology, 2014-10, Vol.740, p.455-463

2014

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Preliminary In vitro Investigation of Bivalent Ligands Containing Homo- and Heterodimeric Pharmacophores at μ, δ, and κ Opioid Receptors

Journal of medicinal chemistry, 2006-01, Vol.49 (1), p.256-262

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(287)

Publikationsform

Artikel
(292)
Reviews
(6)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(150)
Animals
(131)
Life Sciences & Biomedicine
(123)
Pharmacology & Pharmacy
(96)
Biological And Medical Sciences
(73)
Chemistry
(72)
Rats
(68)
Chemistry, Medicinal
(64)
Medical Sciences
(64)
Male
(61)
Pharmacology. Drug Treatments
(58)
Neuropharmacology
(46)
Physical Sciences
(45)
Structure-Activity Relationship
(44)
Humans
(39)
Neurotransmitters. Neurotransmission. Receptors
(38)
Chemistry, Organic
(35)
Brain - Metabolism
(28)
Stereoisomerism
(26)
Apomorphine - Analogs & Derivatives
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders

Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders

The Non-Anhydrous, Minimally Basic Synthesis of the Dopamine D2 Agonist [18F]MCL-524

Identification of fluorinated (R)-(-)-aporphine derivatives as potent and selective ligands at serotonin 5-HT 2C receptor

Identification of fluorinated (R)-(−)-aporphine derivatives as potent and selective ligands at serotonin 5-HT2C receptor

The High Affinity Dopamine D 2 Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological Disorders

The High Affinity Dopamine D2 Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological Disorders

Arylbenzazepines are potent modulators for the delayed rectifier K+ channel: a potential mechanism for their neuroprotective effects

Synthesis of 2-Fluoro-11-hydroxy-N-propylnoraporphine: A Potential Dopamine D2 Agonist

A Tribute to Joseph G. Cannon, 1926–2011

A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey

Advances in Development of Dopaminergic Aporphinoids

The Non-Anhydrous, Minimally Basic Synthesis of the Dopamine D 2 Agonist [18F]MCL-524

Synthesis and Pharmacological Evaluation of Aminothiazolomorphinans at the Mu and Kappa Opioid Receptors

Microwave-Promoted Pd-Catalyzed Cyanation of Aryl Triflates: A Fast and Versatile Access to 3-Cyano-3-desoxy-10-ketomorphinans

Rapid access to morphinones: removal of 4,5-ether bridge with Pd-catalyzed triflate reduction

Kappa receptor bivalent ligands

Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors

Synthesis and Opioid Receptor Binding Affinities of 2-Substituted and 3-Aminomorphinans: Ligands for μ, κ, and δ Opioid Receptors

Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors

Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines

Aminothiazolomorphinans with Mixed κ and μ Opioid Activity

Synthesis, Binding Affinity, and Functional in Vitro Activity of 3-Benzylaminomorphinan and 3-Benzylaminomorphine Ligands at Opioid Receptors

Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with κ agonist and μ agonist/antagonist activity

Synthesis and Preliminary In vitro Investigation of Bivalent Ligands Containing Homo- and Heterodimeric Pharmacophores at μ, δ, and κ Opioid Receptors

Suchergebnisse filtern